CXCL1 and neoplasm: DARC is found to bind angiogenic ELR+ CXC chemokines CXCL-1 and IL-8 and play a negative role in tumor progression through the control of angiogenesis by reducing angiogenic ELR+ CXC chemokine secretion [24].